PHARMACYTE BIOTECH
PharmaCyte Biotech is a clinical stage biotechnology company focused on developing and preparing to commercialize treatments for cancer and diabetes based upon a proprietary cellulose-based live cell encapsulation technology known as Cell-in-a-Box®. This unique and patented technology will be used as a platform upon which treatments for several types of cancer, including advanced, inoperable pancreatic cancer, and diabetes are being built. PharmaCyte Biotech’s treatment for pancreatic... cancer involves low doses of the well-known anticancer prodrug ifosfamide, together with encapsulated live cells, which convert ifosfamide into its active or “cancer-killing” form. These capsules are placed as close to the cancerous tumor as possible to enable the delivery of the highest levels of the cancer-killing drug at the source of the cancer. This “targeted chemotherapy” has proven remarkably effective in past clinical trials. In addition, PharmaCyte Biotech is working towards improving the quality of life for patients with advanced pancreatic cancer and on treatments for other types of solid cancerous tumors. PharmaCyte Biotech is also developing treatments for cancer based upon chemical constituents of marijuana known as cannabinoids. In doing so, PharmaCyte Biotech is examining ways to exploit the benefits of Cell-in-a-Box® technology in optimizing the anticancer effectiveness of cannabinoids, while minimizing or outright eliminating the debilitating side effects usually associated with cancer treatments. This provides PharmaCyte Biotech the rare opportunity to develop “green” approaches to fighting deadly cancers, such as those of the pancreas, brain and breast, which affect hundreds of thousands of individuals worldwide every year.
PHARMACYTE BIOTECH
Industry:
Biotechnology Clinical Trials Health Care Medical Medical Device
Founded:
1996-01-01
Address:
Laguna Hills, California, United States
Country:
United States
Website Url:
http://www.pharmacytebiotech.com
Total Employee:
11+
Status:
Active
Contact:
(917)595-2850
Email Addresses:
[email protected]
Total Funding:
87.14 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Amazon Office 365 Mail GoDaddy DNS AWS Global Accelerator Amazon California Region
Similar Organizations
Ansun BioPharma
Ansun BioPharma is a clinical-stage biopharmaceutical company focused on the development of host-directed anti-viral.
Juventas Therapeutics
Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.
Northwest Biotherapeutics
Northwest Biotherapeutics is a biotechnology company focused on developing and commercializing immunotherapy products to treat cancer.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Senseonics
Senseonics is a medical device startup company that focuses on the design, development, and commercialization of glucose monitoring systems.
Current Advisors List
Current Employees Featured
Stock Details
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2011-07-21 | PharmaCyte Biotech | PharmaCyte Biotech acquired by PharmaCyte Biotech | N/A |
Key Employee Changes
Date | New article |
---|---|
2020-08-10 | PharmaCyte Biotech Appoints Dr. José Iglesias as Consulting Chief Medical Officer for Clinical Trial in Pancreatic Cancer |
Official Site Inspections
http://www.pharmacytebiotech.com
- Host name: a4ec4c6ea1c92e2e6.awsglobalaccelerator.com
- IP address: 15.197.142.173
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "PharmaCyte Biotech" on Search Engine
PharmaCyte Biotech, Inc. (PMCB)
Nov 15, 2023 PharmaCyte Biotech, Inc. (PharmaCyte) is a biotechnology company developing cellular therapies for cancer and diabetes based upon a proprietary cellulose …See details»
PharmaCyte Biotech - Crunchbase Company Profile
PharmaCyte Biotech is a clinical stage biotechnology company focused on developing and preparing to commercialize treatments for cancer and diabetes based upon a …See details»
PharmaCyte Biotech | LinkedIn
PharmaCyte Biotech is a clinical stage biotechnology company focused on developing and preparing to commercialize treatments for cancer and diabetes based upon a proprietary cellulose-based...See details»
PharmaCyte Biotech Announces Launch of New Corporate Website
Mar 9, 2015 PharmaCyte Biotech is a clinical stage biotechnology company focused on developing and preparing to commercialize treatments for cancer and diabetes based …See details»
PharmaCyte Biotech, Inc. | Our Mission
PharmaCyte Biotech is a clinical stage biotechnology company focused on developing and preparing to commercialize treatments for cancer and diabetes based upon a proprietary …See details»
PharmaCyte Biotech Provides Update on Status of …
Jun 24, 2021 PharmaCyte Biotech, Inc. is a biotechnology company developing cellular therapies for cancer and diabetes based upon a proprietary cellulose-based live cell …See details»
PharmaCyte Biotech Provides Corporate Update on Cell-in-a-Box …
LAS VEGAS, October 31, 2023--PharmaCyte Biotech, Inc. (Nasdaq: PMCB) ("PharmaCyte" or the "Company") provides an update on its investigation of its Cell-in-a …See details»
PharmaCyte Biotech, Inc. (PMCB) - Yahoo Finance Canada
GlobeNewswire. Femasys Inc. Secures Additional Financing with Strategic Investment from Investors led by PharmaCyte Biotech. Business Wire. Find the latest PharmaCyte …See details»
PharmaCyte Biotech Announces Closing of $15-Million …
Aug 12, 2021 PharmaCyte Biotech, Inc. is a biotechnology company developing cellular therapies for cancer and diabetes based upon a proprietary cellulose-based live cell …See details»
PharmaCyte Biotech Board of Directors Announces Business
Oct 7, 2022 PharmaCyte is a biotechnology company focused on evaluating its signature live-cell encapsulation technology, Cell-in-a-Box, for potential development of cellular …See details»
PharmaCyte Biotech Provides Corporate Update on Cell-in-a-Box ...
Oct 31, 2023 PharmaCyte is a biotechnology company that is currently evaluating its signature live-cell encapsulation technology, Cell-in-a-Box ®, for potential development …See details»
PharmaCyte Biotech, Inc. | PharmaCyte Biotech Reaches …
LAS VEGAS, NV, August 15, 2022 — (BUSINESS WIRE) — PharmaCyte Biotech, Inc. (NASDAQ: PMCB), a biotechnology company focused on developing cellular therapies …See details»
PharmaCyte Biotech Announces Final Results of Tender Offer
LAS VEGAS, June 15, 2023--PharmaCyte Biotech, Inc. (Nasdaq: PMCB) ("PharmaCyte" or the "Company") today announces the final results of its previously announced tender …See details»
PharmaCyte Biotech - Funding, Financials, Valuation & Investors
PharmaCyte Biotech is a clinical stage biotechnology company focused on developing and preparing to commercialize treatments for cancer.See details»
PharmaCyte Biotech, Inc.: Drug pipelines, Patents, Clinical trials ...
Explore PharmaCyte Biotech, Inc. with its drug pipeline, therapeutic area, technology platform, 105 news, and 7 literature, Disease Domain:Neoplasms, Endocrinology and …See details»
PharmaCyte Biotech Company Profile - Craft
Feb 28, 2024 PharmaCyte Biotech is a clinical-stage biotechnology company focused on developing and preparing to commercialize treatments for cancer and diabetes. It …See details»
PharmaCyte Biotech Releases More Positive Results From FDA …
Sep 21, 2021 PharmaCyte Biotech, Inc. (NASDAQ: PMCB), a biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live …See details»
PharmaCyte Biotech, Inc. | PharmaCyte Biotech Releases More …
Sep 21, 2021 PharmaCyte Biotech, Inc. is a biotechnology company developing cellular therapies for cancer and diabetes based upon a proprietary cellulose-based live cell …See details»
PharmaCyte Biotech to Attend 2022 BIO International ... - BioSpace
Jun 13, 2022 PharmaCyte Biotech, Inc. is a biotechnology company developing cellular therapies for cancer, diabetes and malignant ascites based upon a proprietary cellulose …See details»
PharmaCyte Biotech, Inc. (PMCB): Business Model Canvas
PharmaCyte Biotech, Inc. (PMCB) is at the forefront of revolutionizing the biotechnology industry with its innovative cell-based therapies for the treatment of various diseases. As …See details»